We studied activity of Bordetella pertussis LPS in the LAL test. The mean activity of various series of LPS preparations obtained from B. pertussis cells ranged from 1,950,000 to 2,940,000 endotoxin units/μg (EU/μg). Activity of the LPS preparation obtained from the culture medium supernatant was significantly higher (4,640,000 EU/μg). Activity of the control standard E. coli 055:B5 LPS was 19,500±500 EU/μg. These data indicate that activity of the obtained preparations of B. pertussis LPS in the LAL test is 100-200 times higher than activity of E. coli LPS used as a reference control. It was concluded that the results of the LAL test when assessing the permissible content of B. pertussis endotoxins require correction, probably by introducing a correction factor.
Similar content being viewed by others
References
Alekseeva IA, Perelygina OV, Kolyshkina ED. Pertussis vaccines and the role of Bordetella pertussis lipooligosaccharide in the immune response to pertussis infection and vaccination. BIOpreparaty. Profilaktika, Diagnostilka, Lechenie. 2021;21(1):10-19. https://doi.org/10.30895/2221-996X-2021-21-1-10-19. Russian.
Bacterial Endotoxins. OPhS.1.2.4.0006.15. State Pharmacopoeia of the Russian Federation. XIV ed. Moscow, 2018. Russian.
Basov AA, Tsvirkun OV, Gerasimova AG, Zekoreeva AK. The problem of pertussis in some regions of the world. Infektsiya Immunitet. 2019;9(2):354-362. https://doi.org/10.15789/2220-7619-2019-2-354-362. Russian.
Zaitsev EM, Poddubikov AV, Britsina MV, Mertsalova NU, Ozeretskovskaya MN, Bazhanova IG, Plekhanova NG. Immunobiological properties of Bordetella pertussis lipopolysaccharide in the acellular pertussis vaccine. Zh. Mikrobiol., Epidemiol. Immunol. 2014;(1):20-24. Russian.
Prutskova EV, Cherdantsev AP, Andreeva NP. Vaccines and vaccination against pertussis of adults and children. Infekt. Bol: Novosti, Mneniya, Obuchenie. 2018;7(2):71-77. https://doi.org/10.24411/2305-3496-2018-12008. Russian.
Cherdantsev AP, Prutskova EV, Kostinov MP. New features of pertussis vaccination. Detsk. Infekt. 2020;19(2):58-63. https://doi.org/10.22627/2072-8107-2020-19-2-58-63. Russian.
Kapil P, Merkel TJ. Pertussis vaccines and protective immunity. Curr. Opin. Immunol. 2019;59:72-78. https://doi.org/10.1016/j.coi.2019.03.006
Niedziela T, Letowska I, Lukasiewicz J, Kaszowska M, Czarnecka A, Kenne L, Lugowski C. Epitope of the vaccine-type Bordetella pertussis strain 186 lipooligosaccharide and antiendotoxin activity of antibodies directed against the terminal pentasaccharide-tetanus toxoid conjugate. Infect. Immun. 2005;73(11):7381-7389. https://doi.org/10.1128/IAI.73.11.7381-7389.2005
Ucieklak K, Koj S, Niedziela T. Conserved structural features of core oligosaccharides among the lipopolysaccharides of respiratory pathogens from the genus Bordetella analyzed exclusively by NMR spectroscopy. Int. J. Mol. Sci. 2021;22(3):1029. https://doi.org/10.3390/ijms22031029
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 172, No. 12, pp. 716-718, December, 2021
Rights and permissions
About this article
Cite this article
Nazirov, M.R., Poddubikov, A.V., Kukes, V.G. et al. Quantitative Assay of B. pertussis Lipopolysaccharide. Bull Exp Biol Med 172, 718–720 (2022). https://doi.org/10.1007/s10517-022-05463-w
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-022-05463-w